Chronic cough, defined as a cough persisting for more than eight weeks, is a common yet perplexing clinical scenario. Despite its prevalence, the etiological understanding and management strategies often pose challenges to clinicians. This article aims to offer a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
Chronic cough can be attributed to a myriad of causes, including but not limited to asthma, gastroesophageal reflux disease (GERD), and postnasal drip syndrome. A thorough patient history and physical examination are paramount in identifying potential triggers. The role of diagnostic tests such as spirometry, chest radiography, and laryngoscopy cannot be understated.
Treatment should be tailored according to the underlying cause. For instance, inhaled corticosteroids are beneficial in cough-variant asthma, while proton pump inhibitors are recommended for GERD-associated cough. However, in cases of unexplained chronic cough, a stepwise therapeutic approach may be employed. This includes empirical treatment trials and specialized investigations if necessary.
Emerging therapies such as neuromodulators and speech therapy have shown promise in the management of chronic cough. Neuromodulators like gabapentin and amitriptyline can be considered in refractory cases. Speech therapy, on the other hand, focuses on behavioral strategies to reduce cough severity and frequency.
Chronic cough is a multifactorial condition requiring a comprehensive approach for effective diagnosis and management. Clinicians should be adept at navigating through the potential etiologies and tailoring treatment accordingly. The incorporation of emerging therapies into the treatment algorithm may offer additional benefits. Continued research and clinical trials are necessary to further elucidate the pathophysiology of chronic cough and improve patient outcomes.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation